---
schema_version: "secwatch.filing_event.v1"
accession: "0001826466-23-000033"
form_type: "8-K"
ticker: "NIKA"
cik: "0001145604"
company_name: "NIKA PHARMACEUTICALS, INC"
filed_at: "2023-09-18T23:59:59+00:00"
generated_at: "2026-06-10T14:28:26.420887+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Nika Pharmaceuticals provides Form 10 info, discloses ownership and auditor change as former shell

## Summary
- Change of control completed Apr 1, 2022: Dimitar Savov acquired 87% of common stock for $140,000.
- As of Aug 31, 2023, Savov holds 38.04% common stock and 100% preferred stock, controlling 100% voting power.
- Company ceased to be a shell as of Apr 11, 2022; business focus on TNG production and dietary supplements.
- Auditor changed: dismissed Pinnacle Accountancy Group on Aug 18, 2022; engaged BF Borgers CPA PC on Oct 24, 2022.
- Common stock not traded on any exchange; approximately 64 holders of record as of Sept 14, 2023.

## SEC filing metadata
- accession: 0001826466-23-000033
- form_type: 8-K
- ticker: NIKA
- cik: 0001145604
- company_name: NIKA PHARMACEUTICALS, INC
- filed_at: 2023-09-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 2.01, 9.01, 3.02, 3.03, 5.01, 5.06
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1145604/000182646623000033/0001826466-23-000033-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1145604/000182646623000033/form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001826466-23-000033
- JSON: https://secwatch.observer/filing/0001826466-23-000033.json
- Plain text: https://secwatch.observer/filing/0001826466-23-000033.txt

## Key facts
- M&A Transactions
  NIKA PHARMACEUTICALS, INC underwent a change of control involving Dimitar Slavchev Savov for $140,000 (closed 2022-04-01).
  - Action: change of control
  - Counterparty: Dimitar Slavchev Savov
  - Consideration: $140,000
  - Closing: 2022-04-01
  source text: As a result of the purchase by Dimitar Slavchev Savov of a total of 11,489,000 (87%) shares of common stock of the Company from the Company’s former President and CEO, Mr. Phil E. Ray and certain other shareholders for $140,000, a change in control of the Company occurred as of April 1, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1145604/000182646623000033/0001826466-23-000033-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.